Clinical Trial Update: Antipsychotic Augmentation With L-Dopa [Phase 2]

View source ↗

Summary

Phase 2 trial assessing augmentation of an antipsychotic with L-Dopa in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• L-Dopa (Levodopa)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED